Lexicon Pharmaceuticals, Inc. LXRX
$2.40
-2.83%
at last close
Financials (TTM)
- Revenue
- $41.47 million
- Net Income
- $-61,117,000
- Net Margin
- -147.38%
- Return on Equity
- -35.02%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 6.12
- Price / Sales
- 25.75
Over the trailing twelve months, Lexicon Pharmaceuticals, Inc. generated revenue of $41.47 million and net income of $-61,117,000, a net margin of -147.38%.
At the last closing price of $2.40, LXRX trades at 25.75 times sales, with a market capitalization of $1.07 billion.
Key Stats
- Last Close
- $2.40
- Market Cap
- $1.07 billion
- 52-Week Range
- $0.84 – $2.68
- Average Volume
- 3.00 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.